阿替普酶静脉溶栓治疗急性心肌梗死疗效分析(1)
【摘 要】 目的:探讨阿替普酶静脉溶栓治疗急性心肌梗死患者的效果。方法:选取2017年5月-2019年5月我院收治的急性心肌梗死患者96例,依据治疗方式不同分成两组,对照组应用尿激酶,研究组应用阿替普酶静脉溶栓治疗。观察比较两组治疗前、治疗后的心功能相关指标水平变化及差异。结果:治疗前,两组的心功能相关指标:LVEF、LVEDV及LVESV水平无显著差异(P>0.05);治疗后,两组LVEF水平较治疗前显著升高,且研究组LVEF水平显著高于对照组(P<0.05);两组LVEDV及LVESV水平较治疗前显著降低,且研究组LVEDV及LVESV水平显著低于对照组(P<0.05)。结论:给予急性心肌梗死患者进行治疗的过程中,应用阿替普酶静脉溶栓治疗,可有效改善患者的心功能及相关指标水平,提高临床治疗效果。【关键词】 尿激酶;阿替普酶;静脉溶栓;心功能;急性心肌梗死
【中图分类号】tL541 2 【文献标志码】B 【文章编号】1005-0019(2020)03-046-01
Abstract :objective: to investigate the effect of alteplase intravenous thrombolysis in patients with acute myocardial infarction. Methods: 96 patients with acute myocardial infarction admitted to our hospital from May 2017 to May 2019 were selected and divided into two groups according to different treatment Methods. The control group received urokinase and the research group received alteplase intravenous thrombolysis. The changes and differences of cardiac function related indexes before and after treatment were observed and compared between the two groups. Results: before treatment ......
您现在查看是摘要页,全文长 3392 字符。